Ходжа Н. (hojja_nusreddin) wrote,
Ходжа Н.

With More Mergers, R&D Slows

The pharmaceutical industry has seen plenty of huge mergers over the last 15 years, including several by Pfizer (PFE), and Schering's $14 billion purchase of Organon, a Dutch company, two years ago. But the consolidation has not led to an upsurge of new drugs. Analysts estimate that pharma R&D productivity today is 2/5 of what it was 10 years ago.

Pfizer alone has spent more than $60 billion on R&D over the past eight years but has not produced one drug from its own labs with annual sales surpassing $1 billion. "These mergers tend to have a negative effect on R&D culture in general"
Tags: stock, американа, экономика

  • Post a new comment


    Anonymous comments are disabled in this journal

    default userpic

    Your reply will be screened

    Your IP address will be recorded